Peter M Neupert insider trades
Open-market stock purchases and sales by Peter M Neupert, Director at Adaptive Biotechnologies Corp, from SEC Form 4 filings since Jan 2, 2013.
Track record: 83% of 6 scored buys are up 5% or more since purchase, averaging +62%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 17, 2026 | ADPT Adaptive Biotechnologies Corp | Sold | $378K |
| Aug 17, 2026 | ADPT Adaptive Biotechnologies Corp | Sold | $1M |
| Aug 17, 2026 | ADPT Adaptive Biotechnologies Corp | Sold | $1.8M |
| Aug 17, 2026 | ADPT Adaptive Biotechnologies Corp | Bought (not open market) | — |
| Jun 10, 2026 | FTRE Fortrea Holdings Inc | Bought (not open market) | — |
| May 14, 2026 | FTRE Fortrea Holdings Inc | Bought (not open market) | — |
| Mar 4, 2026 | ADPT Adaptive Biotechnologies Corp | Bought (not open market) | — |
| Feb 11, 2026 | LH Labcorp Holdings Inc | Bought (not open market) | — |
| Feb 10, 2026 | LH Labcorp Holdings Inc | Bought (not open market) | — |